ASA in the News
By Francisco Alvarado for Vice
“Whether or not doctors or other health care professionals have any intention of recommending medical cannabis for patient care, they all need to be well educated in this clinical area because their patients will be seeking their expert advice and guidance for this medication,” noted Stephen B. Corn, MD, a specialist in anesthesiology, perioperative and pain medicine at Brigham and Women’s Hospital and Children’s Hospital, both in Boston. Since patients may already be using medical marijuana, clinicians “need to be aware of the physiological effects of cannabis as well as potential drug interactions and side effects,” Dr. Corn added, stressing that expertise in medical cannabis will be necessary for most doctors, pharmacists, nurses and other health care professionals.
For CBS Miami
“When we look at tools to combat the opioid crisis, I think it’s amazing that medical cannabis is a tool we can use. At the heart of all of our challenges is the fact that the federal government sees cannabis as more dangerous than methamphetamines or cocaine.” - Steph Sherer
Themes Emerging from the 2017 Americans for Safe Access Unity Conference - Americans for Safe Access
By Chloe Detrick for Ganjapreneur
“I feel that ASA is only going to continue growing as more and more states begin introducing legalization efforts. We are going to continue to get involved with state governments and assist them in ensuring that people are doing things the right way.” - Beth Collins
By Marcia Coyle for The National Law Journal
A team from Orrick, Herrington & Sutcliffe, representing the medical marijuana advocate Americans for Safe Access, isn’t holding its breath for federal drug enforcement officials to erase their alleged misstatements about the health risks of cannabis.
The U.S. Drug Enforcement Administration has not responded to a petition from Americans for Safe Access that sought to correct allegedly false and misleading information from the DEA’s website. Orrick filed the petition in late last year.
The next step? A possible lawsuit, said Orrick’s Vickie Feeman, a partner in the firm’s Silicon Valley office who is leading the pro bono effort for the pro-marijuana advocate.
Larger-scale research, better regulation needed
By Ryan Basen for Medpage Today
WASHINGTON -- Medicinal cannabis industry officials and scholars here touted potential breakthroughs to treat health problems and questioned why cannabidiol (CBD) is not mandatory for athletes to address traumatic brain injury (TBI). Others, meanwhile, cautioned the field needs much more research and regulation.
"The whole concept of cannabis as medicine is very new," Stuart Titus, PhD, told MedPage Today during an interview at the Americans for Safe Access (ASA) annual meeting on medical cannabis last week. "Everything is at such a ground-floor state."
By the Associated Press for Fox 8 Cleveland
“The most genuine answer that anyone can give about Ohio’s program is that this has never been done before, so we don’t know if it will work, or serve patients. So patients will just have to wait and see.” - Dr. Jahan Marcu
By Mary Paige Nesfeder for Fox News
“I think that we have a lot of new champions this year that I think are really going to push this issue and end the federal conflict once and for all,” - Steph Sherer
By Tim Devaney for The Hill
Medical marijuana advocates will descend on Capitol Hill Tuesday.
The advocates are in town for the National Medical Cannabis Unity Conference, which culminates in a lobbying day next week.
Without Proper Testing and Training It Could Be
By David Hodes for Dope Magazine
“Some of the information on the Drug Enforcement Administration (DEA) website is 30 or 40 years old,. I don’t know about your health policy, but I prefer mine to be based on policy that is younger than me.” - Jahan Marcu